Results 41 to 50 of about 13,831 (252)

Diagnostic and therapeutic approaches of para‐testicular SCRMS in an adolescent patient: A case report

open access: yesUroPrecision, EarlyView.
Abstract Background Para‐testicular rhabdomyosarcoma (RMS) is a rare and aggressive malignancy primarily affecting children and adolescents, with peak incidence between ages 2 and 5 years. Of the histological variants of RMS, the spindle cell type of RMS is particularly uncommon, accounting for approximately 5% of cases.
Kholoud Alabassi   +5 more
wiley   +1 more source

Combination of Dexmedetomidine and Low-Dose Ketamine in 4 Sugar Gliders (Petaurus breviceps) Undergoing Elective Castration

open access: yesVeterinary Sciences
Four entire male sugar gliders (Petaurus breviceps) belonging to the same colony were presented for elective orchiectomy. After clinical examination, dexmedetomidine (120 μg/kg) in combination with ketamine (5 mg/kg) were administered subcutaneously (SC).
Elisa Silvia D’Urso   +4 more
doaj   +1 more source

AMHR2 mutation in persistent Müllerian duct syndrome: A case of transverse testicular ectopia

open access: yesUroPrecision, EarlyView.
Abstract Backgroud Persistent Müllerian duct syndrome (PMDS) is a rare condition characterized by the persistence of Müllerian duct structures in genotypic and phenotypic males. Case Presentation We present the case of a 4‐month‐old male with PMDS who presented with transverse testicular ectopia. The patient underwent diagnostic laparoscopic orchiopexy
Hangcheng Fu   +2 more
wiley   +1 more source

Assessment of new prognostic risk models for recurrence in patients with clinical stage I seminoma. [PDF]

open access: yesBJU Int
Objectives To evaluate two new prognostic risk models aimed at improving clinical decision‐making in patients with clinical stage (cS) I seminomatous testicular germ cell tumours (GCTs), 5%–30% of whom experience recurrence during surveillance after orchiectomy and may benefit from adjuvant therapy.
Strauch A   +4 more
europepmc   +2 more sources

BRD9 inhibition as potential treatment option for testicular germ cell tumors

open access: yesAndrology, EarlyView.
Abstract Background Testicular germ cell tumors (TGCT) are the predominant tumor in younger males. Usually, 5‐year survival rates are quite high, but 15–20% of patients with metastatic non‐seminomas are resistant to standard cisplatin‐based therapy.
Aylin Hansen   +5 more
wiley   +1 more source

Splenogonadal fusion: a case report of three cases and a literature review

open access: yesFrontiers in Pediatrics
PurposeThis case report aims to enhance the understanding of clinical physicians regarding splenogonadal fusion (SGF) and to help them consider SGF as a differential diagnosis when testicular tumors are suspected, thus avoiding unnecessary orchiectomies ...
Na Luo   +4 more
doaj   +1 more source

A Case of Paratesticular Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma

open access: yesJournal of Urological Surgery, 2015
A very rare case of paratesticular atypical lipomatous tumor/a case of welldifferentiated liposarcoma diagnosed in an elderly patient is presented together with macroscopic surgical photographs and photographs of microscopic pathological sections.
Hikmet Köseoğlu, Kutsal Yörükoğlu
doaj   +1 more source

Semen quality in patients with testicular cancer is associated with age and with greatly elevated levels of beta human chorionic gonadotropin

open access: yesAndrology, EarlyView.
Abstract Background Poor semen quality is a well‐known feature in patients with testicular germ cell tumours (GCTs) at the time of diagnosis but the underlying biological reasons are incompletely understood. Objectives This study aimed to identify GCT‐specific clinical factors that are involved with poor semen quality in GCT patients.
Klaus‐Peter Dieckmann   +9 more
wiley   +1 more source

Luteinizing hormone-releasing hormone agonists versus orchiectomy in the treatment of prostate cancer: A systematic review

open access: yesFrontiers in Endocrinology, 2023
BackgroundOrchiectomy has been replaced by medication represented by luteinizing hormone-releasing hormone (LHRH) agonist as the first-line therapy for androgen deprivation therapy (ADT).
Xianlu Zhang   +3 more
doaj   +1 more source

Detection of germ cell neoplasia in situ and testicular cancer risk in men with testicular microlithiasis: Real world results through 10 years

open access: yesAndrology, EarlyView.
Abstract Background Guidelines recommend biopsies for men <50 years with testicular microlithiasis and cancer risk factors to rule out germ cell neoplasia in situ. Limited data support this practice. Objectives To clarify the significance of testicular microlithiasis by examining pathological findings in men with testicular microlithiasis.
Karoline Skov Lundager   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy